Literature DB >> 18073607

Inhibition of inducible nitric oxide synthase ameliorates lung injury in rats after gut ischemia-reperfusion.

Kotaro Uchida1, Shiro Mishima, Sho-Ichi Ohta, Tetsuo Yukioka.   

Abstract

BACKGROUND: Gut hypoperfusion is considered to be a critical event for organ failure during severe surgical insults. The mechanism of remote organ injury after intestinal ischemia-reperfusion (I/R) may involve the excessive nitric oxide (NO) production; however, its role has been controversial. We sought to determine whether a selective inducible NO synthase inhibitor, aminoguanidine (AG), ameliorates pulmonary microvascular injury after superior mesenteric artery occlusion.
METHODS: Anesthetized rats underwent superior mesenteric artery occlusion for 30 minutes and reperfusion for 6 hours (I/R) or sham operation (control). Another set of animals undergoing I/R received an AG at the end of the ischemia. Pulmonary vascular permeability was assessed by measuring tissue retention of Evans Blue dye that binds albumin. The plasma was harvested and NO2/NO3 (end products of NO) was measured. The bacterial cultures of the mesenteric lymph node of animals were performed to estimate the gut bacterial translocation after injury.
RESULTS: The concentration of NO2/NO3 of plasma in the I/R group was higher than that of the control (p < 0.05). The lung-to-plasma Evans Blue dye ratio in the I/R group was also higher than that of the control (p < 0.01). Treatment with the AG prevented this lung injury induced by the gut I/R. The incidences of gut translocation were not significantly different between the I/R and AG groups.
CONCLUSIONS: Increased lung vascular permeability elicited by gut I/R was significantly attenuated with inhibition of an inducible NO release by AG. Control of bacterial translocation was not needed to prevent lung injury in this model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073607     DOI: 10.1097/TA.0b013e3181271b0b

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Anti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/reperfusion.

Authors:  Ahmet Guzel; Mehmet Kanter; Aygul Guzel; Ahmet Pergel; Mustafa Erboga
Journal:  J Mol Histol       Date:  2012-03-03       Impact factor: 2.611

2.  HB-EGF protects the lungs after intestinal ischemia/reperfusion injury.

Authors:  Iyore A O James; Chun-Liang Chen; Guangcun Huang; Hong-Yi Zhang; Markus Velten; Gail E Besner
Journal:  J Surg Res       Date:  2010-04-24       Impact factor: 2.192

3.  Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo.

Authors:  Jai Prakash; Ruchi Bansal; Eduard Post; Alie de Jager-Krikken; Marjolijn N Lub-de Hooge; Klaas Poelstra
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

4.  Proanthocyanidin protects intestine and remote organs against mesenteric ischemia/reperfusion injury.

Authors:  Ali Sizlan; Ahmet Guven; Bulent Uysal; Omer Yanarates; Abdulkadir Atim; Emin Oztas; Ahmet Cosar; Ahmet Korkmaz
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

5.  Recombinant factor XIII diminishes multiple organ dysfunction in rats caused by gut ischemia-reperfusion injury.

Authors:  Sergey B Zaets; Da-Zhong Xu; Qi Lu; Eleonora Feketova; Tamara L Berezina; Maryann Gruda; Inga V Malinina; Edwin A Deitch; Eva H N Olsen
Journal:  Shock       Date:  2009-06       Impact factor: 3.454

Review 6.  Strategies for modulating the inflammatory response after decompression from abdominal compartment syndrome.

Authors:  Shinil K Shah; Fernando Jimenez; Phillip A Letourneau; Peter A Walker; Stacey D Moore-Olufemi; Randolph H Stewart; Glen A Laine; Charles S Cox
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-04-03       Impact factor: 2.953

7.  Annexin-A1 peptide down-regulates the leukocyte recruitment and up-regulates interleukin-10 release into lung after intestinal ischemia-reperfusion in mice.

Authors:  Bruna Candido Guido; Marianna Zanatelli; Wothan Tavares-de-Lima; Sonia Maria Oliani; Amílcar Sabino Damazo
Journal:  J Inflamm (Lond)       Date:  2013-03-13       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.